Dipexium Pharmaceuticals, Inc. 4
4 · Dipexium Pharmaceuticals, Inc. · Filed Mar 19, 2014
Insider Transaction Report
Form 4
LUCI DAVID P
DirectorPresident, CEO, Secretary10% Owner
Transactions
- Purchase
Common Stock, par value $.001 per share
2014-03-18$12.00/sh+2,083$24,996→ 1,829,447 total - Award
Employee Stock Option (right to buy)
2014-03-18+298,826→ 298,826 totalExercise: $13.93Exp: 2019-03-18→ Common Stock, par value $.001 per share (298,826 underlying)
Holdings
- 7,462(indirect: By Spouse)
Common Stock, par value $.001 per share
Footnotes (2)
- [F1]Excludes 2,800 shares beneficially owned by family members of the Reporting Person, for which the Reporting Person maintains voting control but no pecuniary interest, and disclaims beneficial ownership therein.
- [F2]The option vests in 36 equal monthly installments, with the first installment vesting on April 18, 2014.